Both in Pharmaceuticals
Serina Therapeutics vs PDS Biotechnology
Over the past year SER returned −57.5% and PDSB returned −26.4%; their daily moves had a correlation of 0.02.
SER −57.5% PDSB −26.4%Growth of $1, one year, split-adjusted
| Metric | SER | PDSB |
|---|---|---|
| Price | $2.08 | $0.7429 |
| Market cap | $52.8M | $53.8M |
| Today | +3.48% | −3.00% |
| 1 month | −15.4% | +252.3% |
| 6 months | +15.6% | +38.5% |
| Year to date | +8.7% | −3.5% |
| 1 year | −58.1% | −27.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $19.9M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 79.2% | 276.2% |
| Short % of float | 1.7% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).